Clinical Research

START encompasses a superior team of clinical and research support staff with extensive experience in oncology drug development and patient care. Each department is guided by the highest standards so as to ensure integrity and quality and an uncompromising focus on our patients. Together these departments work toward fulfilling START’s mission to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer.

START's Investigational Drug Section (IDS)

START's Investigational Drug Section (IDS) provides pharmaceutical services for phase I investigational study treatments and conventional chemotherapy treatments.

 

START's Phase I Clinic

START’s Phase I Clinic staff is comprised of a variety of different roles including Registered Nurses, Licensed Vocational Nurses, Medical Assistants, Research Nurses, Study Coordinators, Clinical Research Assistants, and Medical Records staff.

START's Pharmacokinetic (PK) Department

START’s Pharmacokinetic (PK) Department processes and ships all samples for the Phase I and II clinical trials conducted at our clinic.

 

START's Regulatory Affairs Department

START’s Regulatory Affairs Department is the critical link between START and its Sponsors. The mission of START’s Regulatory Affairs Department is to gain necessary approval from the Institutional Review Board(s) to enable patients to be enrolled in investigational studies conducted by START.

 

START Tumor Bank

The START Tumor Bank is a department within the PK Department and handles skin and tumor biopsies required by clinical trial protocols.  Additionally, the START Tumor Bank collects and banks the tumor tissues of patients who consent.  This tissue is then stored for future use by researchers developing new therapies.